Interagency Committee on Smoking and Health (ICSH), 55291 [2020-19642]
Download as PDF
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
automated collection techniques or
other forms of information technology.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov.
Please cite OMB Control No. 9000–
0011, Preaward Survey Forms (Standard
Forms 1403, 1404, 1405, 1406, 1407,
and 1408).
William F. Clark,
Director, Office of Government-wide
Acquisition Policy, Office of Acquisition
Policy, Office of Government-wide Policy.
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–19550 Filed 9–3–20; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2020–19551 Filed 9–3–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health (ICSH)
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 15–352, Occupational Safety and
Health Training Project Grants (TPG).
Date: December 1–2, 2020.
Time: 8:00 a.m.–7:00 p.m., EST.
Place: Virtual Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Official, Office of
Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West
Virginia, 26505, Telephone: (304) 285–
5879; Email: MRidenour@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
VerDate Sep<11>2014
16:42 Sep 03, 2020
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
Notice of Closed Meeting
Jkt 250001
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Interagency
Committee on Smoking and Health
(ICSH). This is a virtual meeting and is
open to the public. The public is
welcome to view the meeting via Zoom,
limited only by the number of seats
available, which is 500. This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below.
DATES: The meeting will be held on
October 15, 2020 from 12:30 p.m. to
4:00 p.m., EDT.
ADDRESSES: Zoom Virtual Meeting. For
more information, including
information regarding registration and
login, please visit: https://www.cdc.gov/
tobacco/about/icsh/index.htm.
FOR FURTHER INFORMATION CONTACT:
Kathryn Gallagher, Alternate Designated
Federal Officer, MPH, Interagency
Committee on Smoking and Health,
CDC, 4770 Buford Highway NE, Atlanta,
Georgia 30341, telephone (404) 639–
6358; kgallagher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Interagency Committee
on Smoking and Health shall provide
advice and guidance to the Secretary,
Department of Health and Human
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
55291
Services (HHS), regarding: (a)
Coordination of research, educational
programs, and other activities within
the Department that relate to the effect
of smoking on human health and on
coordination of these activities, with
similar activities of other Federal and
private agencies; and (b) establishment
and maintenance of liaisons with
appropriate private entities, other
Federal agencies, and State and local
public agencies, regarding activities
relating to the effect of cigarette smoking
on human health.
Matters to be considered: The agenda
will include discussions on the topic of
youth tobacco cessation. The meeting
objective is to identify federal actions to
prioritize areas of research that can be
expedited to support tobacco cessation
treatments for youth. Agenda items are
subject to change as priorities dictate.
Procedure for oral public comment:
All persons interested in making an oral
public comment at the October ICSH
meeting must submit an email request,
according to the instructions provided,
to Jade Chambers-Blair at OSHIM@
cdc.gov, no later than 11:59 p.m., EDT,
October 8, 2020. The email request
should include the speaker’s first and
last name, organization, address, phone,
and email. CDC will allow for as many
comments as permitted by time and will
queue individuals for comment in the
order in which their requests were
received. CDC staff will notify
individuals regarding their request to
speak by email by October 11, 2020. To
accommodate the interest in
participation in the oral public
comment session of ICSH meetings,
each speaker will be limited to 2
minutes, and each speaker may only
speak once per meeting.
For more information on ICSH please
visit the CDC.gov webpage: https://
www.cdc.gov/tobacco/about/icsh/
index.htm.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–19642 Filed 9–3–20; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04SEN1.SGM
04SEN1
Agencies
[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Page 55291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19642]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Interagency Committee on Smoking and Health (ICSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Interagency Committee on Smoking and Health
(ICSH). This is a virtual meeting and is open to the public. The public
is welcome to view the meeting via Zoom, limited only by the number of
seats available, which is 500. This meeting will include time for
members of the public to make an oral comment. Priority will be given
to individuals who submit a request to make an oral public comment
before the meeting according to the procedures below.
DATES: The meeting will be held on October 15, 2020 from 12:30 p.m. to
4:00 p.m., EDT.
ADDRESSES: Zoom Virtual Meeting. For more information, including
information regarding registration and login, please visit: https://www.cdc.gov/tobacco/about/icsh/index.htm.
FOR FURTHER INFORMATION CONTACT: Kathryn Gallagher, Alternate
Designated Federal Officer, MPH, Interagency Committee on Smoking and
Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 30341, telephone
(404) 639-6358; [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Interagency Committee on Smoking and Health shall
provide advice and guidance to the Secretary, Department of Health and
Human Services (HHS), regarding: (a) Coordination of research,
educational programs, and other activities within the Department that
relate to the effect of smoking on human health and on coordination of
these activities, with similar activities of other Federal and private
agencies; and (b) establishment and maintenance of liaisons with
appropriate private entities, other Federal agencies, and State and
local public agencies, regarding activities relating to the effect of
cigarette smoking on human health.
Matters to be considered: The agenda will include discussions on
the topic of youth tobacco cessation. The meeting objective is to
identify federal actions to prioritize areas of research that can be
expedited to support tobacco cessation treatments for youth. Agenda
items are subject to change as priorities dictate.
Procedure for oral public comment: All persons interested in making
an oral public comment at the October ICSH meeting must submit an email
request, according to the instructions provided, to Jade Chambers-Blair
at [email protected], no later than 11:59 p.m., EDT, October 8, 2020. The
email request should include the speaker's first and last name,
organization, address, phone, and email. CDC will allow for as many
comments as permitted by time and will queue individuals for comment in
the order in which their requests were received. CDC staff will notify
individuals regarding their request to speak by email by October 11,
2020. To accommodate the interest in participation in the oral public
comment session of ICSH meetings, each speaker will be limited to 2
minutes, and each speaker may only speak once per meeting.
For more information on ICSH please visit the CDC.gov webpage:
https://www.cdc.gov/tobacco/about/icsh/index.htm.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-19642 Filed 9-3-20; 8:45 am]
BILLING CODE 4163-18-P